Novo Nordisk And Oramed Pharmaceuticals Race To Create An Insulin Pill

An insulin pill, long desired by diabetes doctors and patients but abandoned as not physically viable, could be available by the end of this decade as a tiny Israeli company races a Danish pharmaceutical giant to be first with what could be a multibillion-dollar product.

Read more

Posted in Drugs Glucose & Insulin